Methods of Information in Medicine, Inhaltsverzeichnis Methods Inf Med 1984; 23(01): 1-3DOI: 10.1055/s-0038-1635321 Editorial Schattauer GmbH Medical Technology Assessment: An Emerging Evaluation Methodology M. F. Collen Artikel empfehlen Abstract Artikel einzeln kaufen Volltext Referenzen References 1 Arnstein S. R.. Technology Assessment: Opportunities and Obstacles. IEEE Trans. Syst. Man Cybern. SMC 1977; 7: 571-582. 2 Banta D. H., Behney C. J., Willems J. S.. Costs and their Evaluation. In Banta D. H.. et al. Toward Rational Technology in Medicine.; New York: Springer; 1981 3 Berk A. A., Chalmers T. C. Cost and Efficacy of the Subsitution of Ambulatory for Inpatient Care. New Engl. J. Med 1981; 304: 393-397. 4 Bunker J. P., Barnes B. J., Mosteller F.. Costs, Risks, and Benefits of Surgery. New York: Oxford Univ. Press; 1977 5 Collen M. F.. A Case Study of Mammography. In Medical Technology and the Health Care System: A Study of the Diffusion of Equipment-Embodied Technology.. Washington, D. C: National Academy of Sciences; 1979 6 Collen M. F.. A Study of Multiphasic Health Testing. In Medical Technology and the Health Care System: A Study of the Diffusion of Equipment-Embodied Technology.. Washington, D. C: National Academy of Sciences; 1979 7 Collen M. F.. Cost-Effectiveness of Automated Laboratory Testing. In Young D. S.. et al. (Eds) Clinician and Chemist. Proc. First A. O. Beckman Conf. in Clinical Chemistry.. Washington, D. C: Amer. Ass. Clin. Chem.; 1979 8 Collen M. F.. A Guideline Matrix for Technological System Evaluation. J. med. Syst 1979; 2: 249-254. 9 Collen M. F.. Utilization of Diagnostic X-Ray Examinations. HHS Pub. FDA. 83-8208. Washington, D. C: US Government Printing Office; 1983 10 Collen M. F., Dales L. G., Friedman G. D., Flagle C. D., Feldman R., Siegelaub A. B.. Multiphasic Health Checkup Evaluation Study. 4. Preliminary Cost Benefit Analysis for Middle-Aged Men. Prev. Med 1973; 2: 236-246. 11 Collen M. F., Feldman R., Siegelaub A. B., Crawford D.. Dollar Cost per Positive Test for Automated Multiphasic Screening. New Engl. J. Med 1970; 283: 459-463. 12 Collen M. F., Garfield S. R., Richart R. H., Duncan J. H., Feldman R.. Cost Analyses of Alternative Health Examination Modes. Arch. intern. Med 1977; 137: 73-79. 13 Cooper B. S., Rice D. P.. The Economic Cost of Illness Revisited. Soc. Secur. Bull 1976; 39: 21-36. 14 Drazen E., Metzger J.. Methods for Evaluating Costs of Automated Hospital Information Systems. DHHS Pub. No. (PHS) 81-3283. July 1981; 15 Eddy D. M.. Screening for Cancer: Theory, Analysis and Design. Englewood Cliffs. Prentice-Hall 1980 16 Klarman H. E.. Application of Cost-Benefit Analysis to Health Systems Technology. In Collen M. F.. (Edit.) Technology and Health Care Systems in the 1980’s. DHEW Pub. (HMS) 73-3016. 1973; 17 McNeil B. J.. Pitfalls in and Requirements for Evaluations of Diagnostic Technologies. In Medical Technology, Urban Institute Conference. DHEW Pub. No. (PHS) 79-3254. Sept. 1979; 18 Office of Technology Assessment, US Congress: Assessing the Efficacy and Safety of Medical Technologies. GPO Stock No. 052003-00593-0. Washington, D. C: US Government Printing Office; 1978 19 Office of Technology Assessment, US Congress: The Implications of Cost—Effectiveness Analysis of Medical Technology. GPO Stock No. 052. 003-0765-7. Washington, D. C: US Government Printing Office; 1980 20 Office of Technology Assessment, US Congress: Background Paper No. 3: The Efficacy and Cost Effectiveness of Psychotherapy. GPO Stock No. 052. 003-00783-5. Washington, D. C: US Government Printing Office; 1980 21 Office of Technology Assessment, US Congress: Background Paper No. 2: Case Study No. 4: Cost Effectiveness of Automated Multichannel Chemistry Analyzers. Washington, D. C: US Government Printing Office; 1981 22 Office of Technology Assessment, US Congress: Background Paper No. 2: Case Study No. 6: The Cost Effectiveness of Bone Marrow Transplant Therapy and its Policy Implications. Washington, D. C: US Government Printing Office; 1981 23 Office of Technology Assessment, US Congress: Strategies for Medical Technology Assessment. GPO Stock No. 052-003-008-87-4 Washington, D. C: US Government Printing Office; 1982 24 Patrick K. M., Woolley R.. A Cost-Benefit Analysis of Immunization for Pneumococcal Pneumonia. J. Amer. med. Ass 1981; 245: 473-477. 25 Richart R. H.. Evaluation of a Hospital Computer System. In Collen M. F.. (Edit.) Hospital Computer Systems, pp. 341-417. New York: Wiley; 1974 26 Stange P., Summer A. T.. Predicting Treatment Costs and Life Expectancy for End-Stage Renal Disease. New Engl. J. Med 1978; 298: 372-378. 27 Willems J. S., Sanders R., Riddiough A., Bell C. Cost-Effectiveness of Vaccination against Pneumococcal Pneumonia. New Engl. J. Med 1980; 303: 553-559.
